Belderbos RA, Corneth OBJ, Dumoulin D, Hendriks RW, et al. Atypical B cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC. Eur J Cancer 2024;196:113428.
PMID: 38039777